  See all
 |
Articles: Pharmacology/Therapy |
Prior Articles
Cetuximab-based treatment of metastatic anal cancer: Correlation of response with KRAS mutational status
Oncology (Karger), 11/18/09
Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy
Core Evidence, 11/18/09
Free full text
Evidence Based Medicine
Revew Article
The value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens
Journal of Cancer Research & Clinical Oncology, 11/18/09
Exclusive Author Commentary Preclinical study of prolonged administration of trastuzumab as combination therapy after disease progression during trastuzumab monotherapy
Cancer Chemotherapy and Pharmacology, 11/18/09 Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer
Cancer Chemotherapy and Pharmacology, 11/18/09 A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment
Cancer Chemotherapy and Pharmacology, 11/18/09 Fatal gemcitabine-induced pulmonary toxicity in metastatic gallbladder adenocarcinoma
Cancer Chemotherapy and Pharmacology, 11/18/09 Gemcitabine and carboplatin in the treatment of transitional cell carcinoma of the urothelium: a single centre experience and review of the literature
European Journal of Cancer Care, 11/18/09 Screening of potential molecular targets for colorectal cancer therapy
International Journal of General Medicine, 11/18/09
Free full text
CYT997 Causes apoptosis in human multiple myeloma
Investigational New Drugs, 11/18/09 Effect of bevacizumab in older patients with metastatic colorectal cancer: Pooled analysis of four randomized studies
Journal of Cancer Research & Clinical Oncology, 11/17/09 Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer
Cancer, 11/17/09 Cisplatin and vinorelbine chemotherapy in recurrent vulvar carcinoma
Oncology (Karger), 11/17/09 Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes
Annals of Oncology, 11/17/09
Exclusive Author Commentary The intravenous to oral relative milligram potency ratio of morphine during chronic dosing in cancer pain
Palliative Medicine, 11/17/09 Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma
Leukemia, 11/17/09 Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer
Annals of Internal Medicine, 11/17/09
Evidence Based Medicine
Revew Article
Heat Shock Protein 90 Inhibitors: New Mode of Therapy to Overcome Endocrine Resistance
Cancer Research, 11/17/09 Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer
Annals of Oncology, 11/16/09 North Central Cancer Treatment Group (NCCTG) N0432: Phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer
Annals of Oncology, 11/16/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
